Urethral Stricture Treatment Market, by Type (Posterior Urethral Stricture and Anterior Urethral Stricture), by Treatment (Urethral Dilation, Direct Vision Internal Urethrotomy (DVIU), Urethroplasty (Anastomotic Urethroplasty and Substitution Urethroplast

Urethral Stricture Treatment Market, by Type (Posterior Urethral Stricture and Anterior Urethral Stricture), by Treatment (Urethral Dilation, Direct Vision Internal Urethrotomy (DVIU), Urethroplasty (Anastomotic Urethroplasty and Substitution Urethroplasty), and Others), by Disease Indication (Iatrogenic, Idiopathic, Infection-induced, Trauma, and Others), by End User (Hospitals, Ambulatory Surgical Center, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Urethral stricture is characterized by the narrowing of the calibre of the urethra caused due a scarring resulting from infection or injury. There are two types of urethral strictures, posterior urethral stricture and anterior urethral stricture. Posterior urethral strictures occur due to fibrosis of the posterior urethra or distraction injuries which result from trauma or pelvic fractures. Anterior urethral stricture are the most commonly occurring strictures and are caused due to infection or trauma leading to spongiofibrosis. The condition can be treated with various treatment options such as urethral dilation, direct vision internal urethrotomy (dviu), urethroplasty, and other treatments.
Market Dynamics
Increasing prevalence of urological and kidney related disorders is expected to drive the market growth over the forecast period. According to a study published by the National Center for Biotechnology Information (NCBI) in October 2021, an estimated 1-19% of the Indian population was suffering from urolithiasis. Moreover, product approvals by regulatory authorities are also expected to drive the market growth. For instance, in April 2021, Urotronic, Inc. received the U.S. Food and Drug Administration approval for Optilume drug-coated balloon (DCB) catheter for treatment of male patients suffering from urethral strictures
Adoption of inorganic growth strategies such as acquisitions and collaborations is expected to facilitate the growth of the global urethral stricture treatment market. For instance, in September 2017, Teleflex Incorporated acquired NeoTract, Inc., a medical device company, which focuses on developing and marketing the UroLift System. It is a minimally invasive medical device used to treat lower urinary tract infection (LUTI).
Key features of the study:
This report provides in-depth analysis of the global urethral stricture treatment market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles leading players in the global urethral stricture treatment market based on the following parameters – company overview, financial performance, technology portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Becton, Dickinson and Company, Amecath, Zhejiang Chuangxiang, Medical Technology Co., Ltd, Allium Ltd., SURGIMEDIK, Cook Group, Taewoong Medical Co., Ltd., Teleflex Incorporated, B. Braun Melsungen AG, Coloplast A/S, Boston Scientific Corporation, and Pnn Medical A/S
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future technology launches, government initiatives, technological upgradation, market expansion, and marketing tactics
The global urethral stricture treatment market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers for global urethral stricture treatment market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:
Global Urethral stricture treatment Market, By Type:
Posterior Urethral Stricture
Anterior Urethral Stricture
Global Urethral stricture treatment Market, By Treatment:
Urethral Dilation
Direct Vision Internal Urethrotomy (DVIU)
Urethroplasty
Anastomotic Urethroplasty
Substitution Urethroplasty
Others
Global Urethral stricture treatment Market, By Disease Indication:
Iatrogenic
Idiopathic
Infection-induced
Trauma
Others
Global Urethral stricture treatment Market, By End User:
Hospitals
Ambulatory Surgical Center
Others
Global Urethral stricture treatment Market, By Region:
North America
By Type:
Posterior Urethral Stricture
Anterior Urethral Stricture
By Treatment:
Urethral Dilation
Direct Vision Internal Urethrotomy (DVIU)
Urethroplasty
Anastomotic Urethroplasty
Substitution Urethroplasty
Others
By Disease Indication:
Iatrogenic
Idiopathic
Infection-induced
Trauma
Others
By End User:
Hospitals
Ambulatory Surgical Center
Others
By Country:
U.S.
Canada
Europe
By Type:
Posterior Urethral Stricture
Anterior Urethral Stricture
By Treatment:
Urethral Dilation
Direct Vision Internal Urethrotomy (DVIU)
Urethroplasty
Anastomotic Urethroplasty
Substitution Urethroplasty
Others
By Disease Indication:
Iatrogenic
Idiopathic
Infection-induced
Trauma
Others
By End User:
Hospitals
Clinics
Ambulatory Surgical Center
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Type:
Posterior Urethral Stricture
Anterior Urethral Stricture
By Treatment:
Urethral Dilation
Direct Vision Internal Urethrotomy (DVIU)
Urethroplasty
Anastomotic Urethroplasty
Substitution Urethroplasty
Others
By Disease Indication:
Iatrogenic
Idiopathic
Infection-induced
Trauma
Others
By End User:
Hospitals
Ambulatory Surgical Center
Others
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
Latin America
By Type:
Posterior Urethral Stricture
Anterior Urethral Stricture
By Treatment:
Urethral Dilation
Direct Vision Internal Urethrotomy (DVIU)
Urethroplasty
Anastomotic Urethroplasty
Substitution Urethroplasty
Others
By Disease Indication:
Iatrogenic
Idiopathic
Infection-induced
Trauma
Others
By End User:
Hospitals
Ambulatory Surgical Center
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
By Type:
Posterior Urethral Stricture
Anterior Urethral Stricture
By Treatment:
Urethral Dilation
Direct Vision Internal Urethrotomy (DVIU)
Urethroplasty
Anastomotic Urethroplasty
Substitution Urethroplasty
Others
By Disease Indication:
Iatrogenic
Idiopathic
Infection-induced
Trauma
Others
By End User:
Hospitals
Ambulatory Surgical Center
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Type:
Posterior Urethral Stricture
Anterior Urethral Stricture
By Treatment:
Urethral Dilation
Direct Vision Internal Urethrotomy (DVIU)
Urethroplasty
Anastomotic Urethroplasty
Substitution Urethroplasty
Others
By Disease Indication:
Iatrogenic
Idiopathic
Infection-induced
Trauma
Others
By End User:
Hospitals
Ambulatory Surgical Center
Others
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Becton, Dickinson and Company *
Company Overviews
Technology Portfolio
Financial Performance
Recent Highlights
Strategies
]Amecath
Zhejiang Chuangxiang
Medical Technology Co., Ltd
Allium Ltd.
SURGIMEDIK
Cook Group
Taewoong Medical Co., Ltd.
Teleflex Incorporated
B. Braun Melsungen AG
Coloplast A/S, Boston Scientific Corporation
Pnn Medical A/S
“*” marked represents similar segmentation in other categories in the respective section.